Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 28, 2013

View Archived Issues

Eliquis recommended by NICE in the U.K., launched in Japan

Scripps Research Institute presents new agents for HBV infection

Sunshine Biopharma gives update on Adva-27a testing

Euroscreen receives grant to develop drugs for neurodegenerative diseases

Xellia enters collaboration to combat multidrug-resistant bacteria

Omalizumab evaluated in phase III trial for CIU/CSU

Taiho Pharmaceutical seeks Japanese approval for TAS-102 in recurrent colorectal cancer

Clinical results presented for ragweed AIT in patients with allergic rhinoconjunctivitis

Mapp Biopharmaceutical presents new antibodies against category B biothreats

hiPSCs used to generate cells for treating myelin loss

Boehringer Ingelheim Pharma patents new gamma-secretase modulators

Janssen R&D Ireland patents novel agents for infections

Phosphodiesterase PDE4 inhibitors synthesized at Amakem

Aciex Therapeutics and Portola Pharmaceuticals to develop ophthalmic drugs

Integrated BioTherapeutics begins first-in-human trial of STEBVax

Roche expands access to clinical trial data

FDA stops pediatric trials of Sensipar

XBiotech launches biosimilars business

Io Therapeutics collaborates with the Michael J. Fox Foundation

Clinical trial data presented for taliglucerase alfa in patients with Gaucher's disease

FDA accepts Stedesa NDA resubmission for review

Sanofi launches Dellegra combination tablets in Japan

Phase I clinical results reported for anthrax vaccine AV-7909

Boehringer Ingelheim commences pivotal trial of volasertib in acute myeloid leukemia

Japanese authorities broaden indication for Lyrica to neuropathic pain

Benet Tablets 75 mg available in Japan

Rare Disease Day being celebrated around the world

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...